These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7211986)

  • 1. Adenocarcinoma of the cervix. I. Clinical evaluation and pathologic features.
    Shingleton HM; Gore H; Bradley DH; Soong SJ
    Am J Obstet Gynecol; 1981 Apr; 139(7):799-814. PubMed ID: 7211986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy and survival of early invasive carcinoma of the cervix uteri with metastases to the pelvic nodes.
    Jobson VW; Girtanner RE; Averette HE
    Surg Gynecol Obstet; 1980 Jul; 151(1):27-9. PubMed ID: 7384981
    [No Abstract]   [Full Text] [Related]  

  • 3. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.
    Look KY; Brunetto VL; Clarke-Pearson DL; Averette HE; Major FJ; Alvarez RD; Homesley HD; Zaino RJ
    Gynecol Oncol; 1996 Dec; 63(3):304-11. PubMed ID: 8946863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosquamous carcinoma of the cervix: prognosis in stage IB.
    Yazigi R; Sandstad J; Munoz AK; Choi DJ; Nguyen PD; Risser R
    Obstet Gynecol; 1990 Jun; 75(6):1012-5. PubMed ID: 2342726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
    Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
    Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
    Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
    Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenocarcinoma of the uterine cervix: a study of 73 cases.
    Ireland D; Hardiman P; Monaghan JM
    Obstet Gynecol; 1985 Jan; 65(1):82-5. PubMed ID: 3966028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glassy cell features in adenosquamous carcinoma of the uterine cervix. Histologic, ultrastructural, immunohistochemical, and clinical findings.
    Costa MJ; Kenny MB; Hewan-Lowe K; Judd R
    Am J Clin Pathol; 1991 Oct; 96(4):520-8. PubMed ID: 1716415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of stage I carcinoma of the cervix.
    Park RC; Patow WE; Rogers RE; Zimmerman EA
    Obstet Gynecol; 1973 Jan; 41(1):117-22. PubMed ID: 4682607
    [No Abstract]   [Full Text] [Related]  

  • 11. Adenocarcinoma of the uterine cervix. Prognosis and prognostic significance of histology.
    Korhonen MO
    Cancer; 1984 Apr; 53(8):1760-3. PubMed ID: 6697314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adenocarcinoma of the uterine cervix].
    Inoue Y; Noda K
    Gan No Rinsho; 1989 Oct; 35(13):1610-4. PubMed ID: 2685397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
    Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic grade and prognosis of carcinoma of the cervix.
    Chung CK; Stryker JA; Ward SP; Nahhas WA; Mortel R
    Obstet Gynecol; 1981 May; 57(5):636-42. PubMed ID: 7219913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine features in poorly differentiated and undifferentiated carcinomas of the cervix.
    Barrett RJ; Davos I; Leuchter RS; Lagasse LD
    Cancer; 1987 Nov; 60(9):2325-30. PubMed ID: 2830956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe cervical glandular cell lesions with coexisting squamous cell lesions.
    van Aspert-van Erp AJ; Smedts FM; Vooijs GP
    Cancer; 2004 Aug; 102(4):218-27. PubMed ID: 15368313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of histologic subtype in node-positive early-stage cervical cancer after hysterectomy and adjuvant radiotherapy.
    Zhou J; Zhang WW; Wu SG; He ZY; Sun JY; Yang GF; Li FY
    Int J Surg; 2017 Aug; 44():1-6. PubMed ID: 28583891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glassy cell carcinoma of the uterine cervix. A light and electron microscopic study of five cases.
    Ulbright TM; Gersell DJ
    Cancer; 1983 Jun; 51(12):2255-63. PubMed ID: 6682695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glassy cell carcinoma of the uterine cervix. An ultrastructural study and review.
    Zaino RJ; Nahhas WA; Mortel R
    Arch Pathol Lab Med; 1982 May; 106(5):250-4. PubMed ID: 6896138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Importance of the Site of Recurrence in Patients With Metastatic Recurrent Cervical Cancer.
    Kim TH; Kim MH; Kim BJ; Park SI; Ryu SY; Cho CK
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1124-1131. PubMed ID: 28721896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.